Ex vivo models to evaluate the role of ocular melanin in trans-scleral drug delivery

European Journal of Pharmaceutical Sciences

Volumn 46, Issue 5, 2012, Pages 475-483

  Pescina, Silvia ^a   Santi, Patrizia ^a   Ferrari, Giulio ^b   Padula, Cristina ^a   Cavallini, Pierugo ^c   Govoni, Paolo ^a   Nicoli, Sara ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b IRCCS FONDAZIONE BIETTI   (Italy)

^c AUSL Parma   (Italy)

Author keywords

Choroid Bruch's membrane; Ex vivo model; Melanin; Ocular delivery; Trans scleral

Indexed keywords

LEVOFLOXACIN; MELANIN; METHYLENE BLUE; METHYLPREDNISOLONE SODIUM SUCCINATE; PROPRANOLOL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRUCH MEMBRANE; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; EX VIVO STUDY; EXPERIMENTAL PIG; IN VITRO STUDY; NONHUMAN; PIGMENTATION; PRIORITY JOURNAL; SCLERA;

ADMINISTRATION, OPHTHALMIC; ANIMALS; BINDING SITES; BRUCH MEMBRANE; CHOROID; DIFFUSION; EYE COLOR; MELANINS; METHYLENE BLUE; METHYLPREDNISOLONE HEMISUCCINATE; OFLOXACIN; PERMEABILITY; PHARMACEUTICAL PREPARATIONS; PROPRANOLOL; SCLERA; SWINE;

EID: 84861186800     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2012.03.013     Document Type: Article

References (26)

1. A.C. Amrite, V. Pugazhenthi, N.P. Cheruvu, and U.B. Kompella Delivery of celecoxib for treating diseases of the eye: influence of pigment and diabetes Expert. Opin. Drug Deliv. 7 2010 631 645
2. B.D. Anderson, and V. Taphouse Initial rate studies of hydrolysis and acyl migration in methylprednisolone 21-hemisuccinate and 17-hemisuccinate J. Pharm. Sci. 70 1981 181 186
3. S. Carda-Broch, and A. Berthod pH dependence of the hydrophobicity of beta-blocker amine compounds measured by counter-current chromatography J. Chromatogr. A 995 2003 55 66
4. N.P.S. Cheruvu, A.C. Amrite, and U.B. Kompella Effect of eye pigmentation on transscleral drug delivery Invest. Ophthalmol. Vis. Sci. 49 2008 333 341
5. S. Duvvuri, S. Majumdar, and A.K. Mitra Role of metabolism in ocular drug delivery Curr. Drug Metab. 5 2004 507 515
6. M. Fukuda, Y. Morita, K. Sasaki, and Y. Yamamoto Studies on the binding mechanism of fluoroquinolones to melanin J. Infect. Chemother. 6 2000 72 76
7. L. Hong, and J.D. Simon Current understanding of the binding sites, capacity, affinity, and biological significance of metals in melanin J. Phys. Chem. B 111 2007 7938 7947
8. A.A. Hussain, C. Starita, A. Hodgetts, and J. Marshall Macromolecular diffusion characteristics of ageing human Bruch's membrane: implications for age-related macular degeneration (AMD) Exp. Eye Res. 90 2010 703 710
9. R.S. Kadam, N.P. Cheruvu, H.F. Edelhauser, and U.B. Kompella Sclera-choroid-RPE transport of eight beta-blockers in human, bovine, porcine, rabbit, and rat models Invest. Ophthalmol. Vis. Sci. 52 2011 5387 5399
10. S.H. Kim, R.J. Lutz, N.S. Wang, and M.R. Robinson Transport barriers in transscleral drug delivery for retinal diseases Ophthal. Res. 39 2007 244 254
11. M.J. Koeberle, P.M. Hughes, G.G. Skellern, and C.G. Wilson Binding of memantine to melanin: influence of type of melanin and characteristics Pharm. Res. 20 2003 1702 1709
12. B.S. Larsson Interaction between chemicals and melanin Pigm. Cell Res. 6 1993 127 133
13. Y. Liu, and J.D. Simon The effect of preparation procedures on the morphology of melanin from the ink sac of Sepia officinalis Pigm. Cell Res. 16 2003 72 80
14. K.J. Mellish, R.D. Cox, D.I. Vernon, J. Griffiths, and S.B. Brown In vitro photodynamic activity of a series of methylene blue analogues Photochem. Photobiol. 75 2002 392 397
15. S. Pescina, P. Santi, G. Ferrari, and S. Nicoli Trans-scleral delivery of macromolecules Ther. Deliv. 2 2011 1331 1349
16. L. Pitkanen, V.-P. Ranta, A. Moilanen, and A. Urtti Binding of betaxolol, metoprolol and oligonucleotides to synthetic and bovine ocular melanin, and prediction of drug binding to melanin in human choroid-retinal pigment epithelium Pharm. Res. 24 2007 2063 2070
17. A.M. Potts The reaction of uveal pigment in vitro with polycyclic compounds Invest. Ophthalmol. Vis. Sci. 3 1964 405 416
18. L.A. Remington Clinical Anatomy and Physiology of the Visual System 2012 Elsevier St. Louis
19. J.C. Rojas, J.M. John, J. Lee, and F. Gonzales-Lima Methylene blue provides behavioral and metabolic neuroprotection against optic neuropathy Neurotox. Res. 15 2009 260 273
20. L. Salminen, A. Urtti, and L. Periviita Effect of ocular pigmentation on pilocarpine pharmacology in the rabbit eye. I. Drug distribution and metabolism Int. J. Pharm. 18 1984 17 24
21. M.J. Sauer, and S.P.L. Anderson In vitro and in vivo studies of drug residue accumulation in pigmented tissues Analyst 119 1994 2553 2556
22. C. Starita, A.A. Hussain, A. Patmore, and J. Marshall Localization of the site of major resistance to fluid transport in Bruch's membrane Invest. Ophthalmol. Vis. Sci. 38 1997 762 767
23. J.P. Tardivo, A. Del Giglio, C. Santos de Oliveira, D.S. Gabrielli, H. Couto Junqueira, D. Batista Tada, D. Severino, R. de Fátima Turchiello, and M.S. Baptista Methylene blue in photodynamic therapy: from basic mechanisms to clinical applications Photodiagnosis Photodyn.Ther. 2 2005 175 191
24. A. Urtti, L. Salminen, H. Kujari, and V. Jäntti Effect of ocular pigmentation on pilocarpine pharmacology in the rabbit eye II. Drug response Int. J. Pharm. 19 1984 53 61
25. K. Wakamatsu, D.N. Hu, S.A. McCormick, and S. Ito Characterization of melanin in human iridal and choroidal melanocytes from eyes with various colored irides Pigm. Cell Melanoma Res. 21 2008 97 105
26. X. Zhang, J.C. Rojas, and F. Gonzales-Lima Methylene blue prevents neurodegeneration caused by rotenone in the retina Neurotox. Res. 9 2006 47 57